Summary - NYXH - NASDAQ - Weiss Ratings

D

Nyxoah SA NYXH

$6.38 -$0.01-0.16% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$4.35 - $11.87

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Nyxoah's (NYXH) "Sell (D-)" Rating Reiterated at Weiss Ratings

10/10/2025 - MarketBeat

How The Pieces Add Up: BMED Headed For $32

10/9/2025 - ETF Channel

Nyxoah SA (NYXH, $6.52) RSI Indicator left the overbought zone on October 07, 2025

10/8/2025 - Tickeron - Stocks

Nyxoah Shares Rise on First U.S. Commercial Use of Genio System

10/7/2025 - Zacks Investment Research

US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder

10/6/2025 - Stocktwits News Feed

Nyxoah (NYXH) Achieves Milestone with First U.S. Genio System Implants

10/6/2025 - GuruFocus

Nyxoah implants first U.S. commercial patients with Genio system

10/6/2025 - The Fly

Nyxoah Launches Genio System In U.S. With First Commercial Implants For Sleep Apnea

10/6/2025 - Nasdaq News: Markets

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio System

10/6/2025 - Globe Newswire

Nyxoah (NYXH) Gets a Buy from Kepler Capital

10/5/2025 - TipRanks Financial Blog

Publication relating to transparency notifications

10/3/2025 - Globe Newswire

Nyxoah Expands in the Middle East to Provide Wider Access to Genio

10/2/2025 - Zacks Investment Research

Nyxoah SA (NYXH, $4.6) RSI Indicator left the oversold zone on September 30, 2025

10/1/2025 - Tickeron - Stocks

Does Nyxoah's Patent Lawsuit Alter the Bull Case for Inspire Medical Systems (INSP)?

9/27/2025 - Simply Wall St

Nyxoah SA (NYXH, $4.79) RSI Indicator left the oversold zone on September 24, 2025

9/25/2025 - Tickeron - Stocks

Nyxoah (NASDAQ:NYXH) Shares Down 3.6% - Time to Sell?

9/24/2025 - MarketBeat

Nyxoah Provides an Update on Expanded Middle East Presence

9/23/2025 - GuruFocus

Nyxoah Provides an Update on Expanded Middle East Presence

9/23/2025 - Globe Newswire

Inspire Medical Systems (INSP): Valuation in Focus Following Patent Lawsuit from Nyxoah

9/23/2025 - Simply Wall St

Nyxoah SA (NYXH, $4.94) RSI Indicator left the oversold zone on September 19, 2025

9/20/2025 - Tickeron - Stocks

Kepler Capital Remains a Buy on Nyxoah (NYXH)

9/18/2025 - TipRanks Financial Blog

How Legal and Regulatory Headwinds at Inspire Medical Systems (INSP) Have Changed Its Investment Story

9/17/2025 - Simply Wall St

Nyxoah SA (NYXH, $4.77) price may climb as it broke lower Bollinger Band on Sep 15, 2025

9/16/2025 - Tickeron - Stocks

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems

9/15/2025 - Nasdaq News: Markets

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

9/15/2025 - GuruFocus

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Monday, August 18, 2025

Period Date

Monday, June 30, 2025

Next Filing

Week of Nov 3 and 7 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

--

52-week Low

Sep 26, 2025 - $4.35

52-week High

Mar 25, 2025 - $11.87

Valuation

Market Cap

$259.30M - Micro Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

32 1 022 23 55

Address

Rue Edouard Belin 12
Mont-Saint-Guibert, 1435

Country

Year Founded

Business Description

Sector

Industry

Health Care Equipment and Services

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked... more